NCT02058511

Brief Summary

The study comprises of a series of pupillary measurements using infrared pupillometry in patients undergoing arthroscopic knee surgery of any type. Infrared pupillometry will be used to assess whether a painful stimulus results in pupillary reflex dilation (PRD). The extend of the PRD may be an indicator how painful a stimulus is. This may help to predict the amount of discomfort a patient will be experiencing after emergence from general anesthesia. In addition to measuring the pupillary reflex dilation, we will also measure oscillations of pupil size before and after indiction of anesthesia, as well as during recovery. These spontaneously occuring oscillations in pupil size, also called hippus, appear to be sensitive to anesthetics and opioids. However, the effect of these drugs on hippus has not been systematically addressed. The aim of the study is

  1. 1.to identify whether regional anesthesia techniques such as femoral and sciatic nerve blocks will block the PRD. This would allow assessment of block success in the anesthetized patient.
  2. 2.to correlate the extent of the pupillary reflex dilation and hippus in the anesthetized patient during and at the end of surgery with early postoperative pain scores and subsequent analgesia requirements. Such correlation would allow to predict the amount of postoperative pain before the patients emerge from general anesthesia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Nov 2012

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 10, 2014

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

February 15, 2019

Completed
Last Updated

February 15, 2019

Status Verified

February 1, 2019

Enrollment Period

4 years

First QC Date

February 4, 2014

Results QC Date

December 6, 2018

Last Update Submit

February 13, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain in Recovery Room

    Pain as assessed by visual analogue score at arrival of the patient in the recovery room Scale goes from 0-10, with 10 indicating the worst pain possible

    at arrival in recovery room

Secondary Outcomes (1)

  • Number of Patients we Were Able to Elicit a PLR Under Stable Experimental Conditions

    measurements were taken at two time points during surgery. Each measurement took 30 seconds

Other Outcomes (1)

  • Hippus

    Before anesthesia start (baseline measurement) until discharge of the patient (on average 1-2 hours after arrival in the recovery room)

Study Arms (1)

Intervention Group

EXPERIMENTAL

all enrolled patients undergo the same protocol/ treatment: Anesthesia Premedication, Induction and Maintenance Pupillometry after administration of anesthetic drugs

Drug: Anesthesia Premedication, Induction and MaintenanceProcedure: Pupillometry after administration of anesthetic drugs

Interventions

The enrolled patients receive standard of care general anesthesia for knee arthroscopy. No additional pharmacological interventions are performed in study participants. The administered drugs, as outlined in the arms section, are midazolam, fentanyl, propofol, and sevoflurane. Study patients receive analgesic drugs as needed in the recovery room if they experience pain.

Intervention Group

All study patients receive the standard of anesthetic care. Every time a anesthetic drug has been administered, changes in pupillary oscillations will be recorded. Assessment of pupil size and movements by shining infrared light into the eye and measuring the reflection over a 20 s period The administered drugs are: Midazolam 1-2 mg iv, Fentanyl 1mcg/kg body weight, Propofol for anesthesia induction 2-2.5 mg/kg body weight, Sevoflurane as needed for maintenance of general anesthesia.

Intervention Group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years undergoing arthroscopic knee surgery of any type

You may not qualify if:

  • Blindness
  • Anisocoria
  • History of opioid abuse
  • Chronic pain patients
  • Gastric Reflux Disease (due to the use of laryngeal masks in the study)
  • Non english speaking patients
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthopedic Institute

San Francisco, California, 94158, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Neoadjuvant TherapyMaintenance

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsHealth Care Facilities Workforce and Services

Limitations and Caveats

In patients under general anesthesia the PLR could not be seen with the stimulus chosen for the experiment. PLR recorded at the end of surgery were attributable to a lack of anesthesia. The trial was terminated after 24 subjects participated.

Results Point of Contact

Title
Matthias Behrends
Organization
UCSF

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor

Study Record Dates

First Submitted

February 4, 2014

First Posted

February 10, 2014

Study Start

November 1, 2012

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

February 15, 2019

Results First Posted

February 15, 2019

Record last verified: 2019-02

Locations